Have a feature idea you'd love to see implemented?
Let us know!
HOLX Hologic Inc
Price (delayed)
$71.65
Market cap
$16.26B
P/E Ratio
21.39
Dividend/share
N/A
EPS
$3.35
Enterprise value
$16.65B
Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. In late November 2013, activist investor Carl Icahn
Highlights
The EPS has surged by 81% year-on-year and by 14% since the previous quarter
Hologic's net income has surged by 73% YoY and by 13% QoQ
Hologic's quick ratio has decreased by 8% QoQ but it has increased by 2.2% YoY
Key stats
What are the main financial stats of HOLX
Market
Valuations
Earnings
Shares outstanding
226.94M
Market cap
$16.26B
Enterprise value
$16.65B
Price to earnings (P/E)
21.39
Price to book (P/B)
3.24
Price to sales (P/S)
4.19
EV/EBIT
16.87
EV/EBITDA
12.85
EV/Sales
4.13
Revenue
$4.03B
Gross profit
$2.23B
Net income
$789.5M
EBIT
$987.2M
EBITDA
$1.3B
Free cash flow
$1.15B
Per share
Balance sheet
Liquidity
EPS
$3.35
EPS diluted
$3.32
Free cash flow per share
$4.86
Book value per share
$22.09
Revenue per share
$17.1
TBVPS
$20.65
Total assets
$9.16B
Total liabilities
$4.03B
Debt
$2.55B
Equity
$5.13B
Working capital
$2.79B
Debt to equity
0.5
Current ratio
3.69
Quick ratio
2.83
Net debt/EBITDA
0.3
Margins
Efficiency
Dividend
EBITDA margin
32.2%
Gross margin
55.3%
Net margin
19.6%
Operating margin
21.9%
Return on assets
9%
Return on equity
16.1%
Return on invested capital
24%
Return on capital employed
12.2%
Return on sales
24.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HOLX stock price
How has the Hologic stock price performed over time
Intraday
1.26%
1 week
-2.72%
1 month
-8.19%
1 year
1.89%
YTD
0.28%
QTD
-12.04%
Financial performance
How have Hologic's revenue and profit performed over time
Revenue
$4.03B
Gross profit
$2.23B
Operating income
$884.3M
Net income
$789.5M
Gross margin
55.3%
Net margin
19.6%
The company's net margin has surged by 73% YoY and by 11% QoQ
Hologic's net income has surged by 73% YoY and by 13% QoQ
The operating margin has grown by 35% YoY and by 11% from the previous quarter
Hologic's operating income has increased by 35% YoY and by 13% QoQ
Growth
What is Hologic's growth rate over time
Valuation
What is Hologic stock price valuation
P/E
21.39
P/B
3.24
P/S
4.19
EV/EBIT
16.87
EV/EBITDA
12.85
EV/Sales
4.13
The EPS has surged by 81% year-on-year and by 14% since the previous quarter
The stock's price to earnings (P/E) is 30% less than its last 4 quarters average of 30.7 and 24% less than its 5-year quarterly average of 28.2
HOLX's price to book (P/B) is 25% lower than its 5-year quarterly average of 4.3 and 12% lower than its last 4 quarters average of 3.7
HOLX's equity is up by 3.6% since the previous quarter and by 2.3% year-on-year
HOLX's price to sales (P/S) is 7% lower than its last 4 quarters average of 4.5 but 4.8% higher than its 5-year quarterly average of 4.0
Efficiency
How efficient is Hologic business performance
Hologic's return on assets has surged by 84% YoY and by 13% QoQ
The ROE has soared by 81% YoY and by 12% from the previous quarter
HOLX's return on invested capital is up by 26% year-on-year and by 6% since the previous quarter
The return on sales is up by 26% year-on-year and by 7% since the previous quarter
Dividends
What is HOLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HOLX.
Financial health
How did Hologic financials performed over time
The total assets is 127% higher than the total liabilities
Hologic's current ratio has decreased by 8% from the previous quarter but it has increased by 6% YoY
Hologic's quick ratio has decreased by 8% QoQ but it has increased by 2.2% YoY
The company's debt is 50% lower than its equity
Hologic's debt to equity has decreased by 12% YoY and by 3.8% from the previous quarter
The company's debt fell by 10% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.